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Abstract 
Abscisic acid (ABA) plays an essential function in plant physiology since   
it is required for biotic and abiotic stress responses as well as control of 
plant growth and development. A new family of soluble ABA receptors, 
named PYR/PYL/RCAR, has emerged as ABA sensors able to inhibit the 
activity of specific protein phosphatases type-2C (PP2Cs) in an ABA-
dependent manner. The structural and functional mechanism by which 
ABA is perceived by these receptors and consequently leads to inhibition 
of the PP2Cs has been recently elucidated. The module PYR/PYL/RCAR-
ABA-PP2C offers an elegant and unprecedented mechanism to control 
phosphorylation signaling cascades in a ligand-dependent manner. The 
knowledge of their three-dimensional structures paves the way to the 
design of ABA agonists able to modulate the plant stress response.     
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1. Introduction 
ABA plays a pivotal role to coordinate plant response under water stress 
situations as well as to regulate plant growth and development [1]. 
Chemically, ABA (C15H20O4) is a sesquiterpenoid derived from isopentenyl 
pyrophosphate synthesized in plastids through the 2C-methyl-D-erythritol-
4-phosphate (MEP) pathway[2]. ABA contains one asymmetric carbon 
atom at C1´, the natural form is S(+)ABA and the side chain of the 
molecule is present in the 2-cis,4-trans isomeric state (Fig. 1). A plane of 
symmetry can be defined in the ABA molecule through the optical center, 
which defines two sides that differ only in that C6´carries two methyl 
group whereas C2´carries one and a double bond. Consequently, the non-
natural (-)enantiomer only differs structurally in these positions from the 
(+)enantiomer (Fig. 1B) [3].  
 Plant hormone research has greatly benefited from genetic screenings 
aimed at the identification of key components of the hormone signaling 
pathways. Arabidopsis mutants showing reduced or enhanced sensitivity to 
a hormone usually pointed out to critical loci that, once cloned, revealed 
crucial components of the hormone signaling pathway [4]. However, such 
screenings, although highly successful for different hormone signaling 
pathways, failed to identify ABA receptors. Functional redundancy or 
pleiotropic effects including embryo or gamete lethality looked as sound 
arguments to justify this failure. Indeed, the first approaches to identify 
ABA receptors, marked by retracted data in one case [5], used biochemical 
techniques to identify ABA-binding proteins (CHLH/ABAR/GUN5) [6] or 
followed pharmacological evidence suggesting the involvement of G-
protein coupled signaling in the ABA pathway (GTG1/GTG2) [7]. Finally, 
a chemical genetic approach using a synthetic selective ABA agonist, 
pyrabactin, made it possible to identify a family of soluble ABA receptors, 
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named PYR/PYL/RCAR for PYRABACTIN RESISTANCE1/PYR1-
LIKE/ REGULATORY COMPONENTS OF ABA RECEPTORS, 
respectively [8, 9]. In a convergent approach, yeast-two hybrid screenings 
[9,10] and in planta interaction studies [11] identified these receptors 
through their capacity to bind to phosphatases type-2C (PP2Cs), which are 
key negative regulatory components of the pathway involved in the 
dephosphorylation  of certain sucrose non-fermenting 1-related subfamily 2 
(SnRK2) kinases [12,13,14].  
 The PYR/PYL/RCAR family of ABA receptors has witnessed a 
rapid explosion of structural data, since five independent groups have 
reported structural and functional mechanisms on ABA signaling 
[15,16,17,18,19], and even more recently, using the seed ABA-agonist 
pyrabactin (Fig. 1C), the structural basis for selective activation of certain 
receptors and the mechanism of antagonism in other members [20,21,22].   
Such wealth of structural information is not available for other ABA 
receptors, such as the Mg-chelatase H subunit and the GTG1/GTG2 
proteins, therefore we will focus this review on the recent structural data 
reported for the PYR/PYL/RCAR ABA receptors and their inhibitory 
interaction with PP2Cs. Additionally, different studies have provided a 
clear connection of PYR/PYL/RCAR receptors with downstream signaling 
components, such as PP2Cs, SnRK2s and ABA-responsive elements 
binding factors (ABFs/AREBs) or the SLOW ANION CHANNEL 1 
(SLAC1) , whose key role in ABA signaling had been previously revealed 
by biochemical and genetic studies. These findings have been recently 
reviewed [1, 23]. 
   
2. The structure of PYR/PYL/RCAR receptors 
The crystal structure of three ABA receptors, PYR1, PYL1 and PYL2, has 
been reported to date (see Protein Data Bank codes in Table 1). As 
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predicted, these data confirm that the PYR/PYL/RCAR family belongs to a 
branch of the Bet v superfamily, which is structurally characterized by the 
presence of the Bet v fold or START domain [24]. This structure comprises 
a seven-stranded -sheet flanked by two -helices, which is designated as 
helix-grip fold. Additionally, the PYR/PYL/RCAR family contains a -
helical segment at the N-terminus, which is not present in the Bet v fold 
and therefore, it can be considered as a particular feature of this family of 
ABA receptors.  
 Crystal structures were obtained both in the apo form (ABA-free) 
and in the presence of ABA. For instance, apoPYL1 [15], apoPYL2 
[15,19], ABA-bound PYL1 [16] and ABA-bound PYL2 [15,19] structures 
have been resolved. In the case of PYR1, in the crystallographic 
asymmetric unit, there is one ABA-bound and one ABA-free subunit 
[17,18]. A high degree of structural similarity is evident from the 
superposition of the three structures (Fig. 2), however, recent works using 
the pyrabactin molecule reveal subtle differences among the receptor 
binding pockets with important functional consequences, since pyrabactin 
is an agonist of PYR1 and PYL1, whereas it is an antagonist of PYL2 [20, 
21, 22].  Different experimental data indicate that these receptors exist as 
dimers in solution, however, the receptor-PP2C complexes have a 1:1 
stoichiometry, implying that the receptor dimers have to dissociate before 
interacting with the PP2C[17,18,19].  
 
2.1. ABA-binding pocket  
The structure of the ABA-bound forms of PYR1, PYL1 and PYL2 reveals 
the nature of the interactions stabilizing the hormone into the receptor 
binding pocket [15,16,17,18,19]. The ABA sits in a deep cavity almost 
completely buried from the external medium (see figure 3). The walls of 
this cavity match perfectly the chemical character of the different 
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functional groups of the hormone.  The cyclohexane ring and the isoprene 
moiety establish hydrophobic interactions with apolar PYR1 side chains, 
while the carboxylic, hydroxyl and ketone groups of the ABA molecule are 
stabilised through interactions with polar side chains. Strikingly, many of 
these polar interactions involve hydrogen bonds with water molecules 
(which are sandwiched between the hormone and the walls of the receptor 
cavity) rather than direct side chain hormone contacts. For instance, the 
carboxylate group of ABA establishes interactions with the side chains of 
Glu94, Glu141, Ser122 and Tyr120 through hydrogen bonds mediated by 
three internal water molecules (Fig. 3). Additionally, a direct polar contact 
is found between the amine group of Lys59 and the carboxylate group, 
which is buried into the ABA binding pocket, away from the loops flanking 
the entry. These data are in agreement with the requirement of the 
carboxylate group for ABA bioactivity [3], and indeed, different mutations 
in these residues, e.g. Glu94Lys, Glu141Lys, Lys59Gln,  abolish or reduce 
PYR1 function. In this context, it is interesting to mention that coupling of 
ABA through its carboxylic group to the amino group of a 10-atom spacer 
arm of a Sepharose resin has been used as a tool to identify ABA binding 
proteins, which resulted in the identification of the Mg-chelatase H subunit 
as an ABA receptor [6,25]. Such approach is likely to interfere with the 
binding of the carboxylate group to the receptor, so the mechanism of ABA 
binding by Mg-chelatase has still to be explained. The addition of bulky 
groups to any part of the hormone molecule is likely to interfere with 
binding to PYR/PYL/RCAR receptors, since this kind of receptor wraps 
very tightly around the hormone. 
 The architecture of the ABA-binding pocket and the structure of 
ABA enantiomers suggest that both molecules can be accommodated into 
the pocket of at least some PYL receptors, although with different affinity. 
Stereospecificity would be contributed by steric constraints imposed by the 
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mono-methyl group at position C2´ and the dimethyl group at C6´. Indeed, 
binding of (-)ABA to the PYL5 receptor has been measured using 
isothermal titration calorimetry [10], although the Kd for the natural 
(+)enantiomer was 20-fold lower (1.1 versus 19.1 M), which indicates a 
higher affinity for ABA binding of the natural form. Additionally, (-)ABA 
promoted interaction of PYL2, PYL3 and PYL4 with HAB1 [8]. Structural 
studies on PYL2 also show that the minus enantiomer can be 
accommodated into the ABA-binding pocket [19], although the dimethyl 
group flipped in the (-)enantiomer would cause some steric hindrance with 
the narrow pocket that accommodates the monomethyl group [15].  
 
2.2. ABA-induced conformational changes 
Since the PYR1 dimer crystal structure contains both unbound and ABA-
bound subunits, comparison of both structures made it possible to reveal 
the ABA-induced subunit conformational changes (Fig. 4A and 4B) 
[17,18]. Thus, superposition of the ABA-bound and ABA-free subunits of 
the PYR1 dimer revealed notable differences in two loop regions (loops 
3-4 y 5-6) and the N-terminal part of the C-terminal -helix. 
Specifically, the loop 3-4 (S85GLPA89) and the loop 5-6 (H115RLT118), 
upon ABA-binding, fold over ABA to complete ABA enclosure, in 
contrast, in the ABA-free subunit, these loops adopt an open conformation  
that allows entry of ABA into the cavity and hence  they have been called 
the gating loops. The region comprising the loop between 7 and the N-
terminal part of the last -helix (M147PEGNSEDDTRM158) is also involved 
in the stabilization of the closed conformation of the gating loops, as well 
as in interaction with the PP2C. Indeed, in addition to trapping the ABA 
molecule into the receptor cavity, these conformational changes are crucial 
to generate a favourable interaction surface for the binding of the PP2C 
(Fig. 4C and 4D). For instance, the mutations P88S and S152L severely 
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reduce the capacity of PYR1 to interact with HAB1. Another key example 
is the flipping movement of S85 (equivalent to S89 in PYL2 and S112 in 
PYL1), which is exposed in the surface of PYR1 upon binding of ABA. 
This residue is crucial for the interaction with the active site of the PP2C 
(discussed below). 
 Similar conclusions have been obtained by comparison of the ABA-
free and ABA-bound forms of dimeric PYL2 [19]. In addition, these 
authors have analysed the changes generated in the dimer interface of 
PYL2 upon ABA binding. ABA binding induces a slight change in the 
relative orientation of one PYL2 protomer with respect to the other. As a 
result, a significant rearrangement of the interface residues is generated, 
leading to a diminished number of van der Waals contacts and hydrogen 
bonds and consequently a weakening of the dimer interface. SAXS studies 
performed with PYR1 also reveal significant changes in the dimer 
assembly upon ABA-binding, which leads to a flatter, more compact form 
of PYR1, which also indicates an orientation change between both subunits 
[17]. 
 
3. Architecture of ternary complexes PYR/PYL/RCAR-ABA-PP2C 
The crystal structure of two ternary complexes has been described, i.e. 
PYL1-ABA-ABI1 and PYL2-ABA-HAB1 [15,16,19]. It is important to 
note that only the catalytic core of the ABI1 (residues 125-429) and HAB1 
(residues 172-511) PP2Cs has been used for these studies. Therefore, it has 
not yet been elucidated the structure of the N-terminal region of the PP2Cs, 
which is expected to play an important role either for biochemical 
regulation of PP2C activity or for regulation of the interaction with other 
partners.  
 First of all, these works provide the first structures of plant PP2Cs, 
and comparison with the pre-existing structure of human PP2C reveals that 
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the active-site residues are highly conserved (Fig. 5 and 6). Thus, critical 
active-site residues of ABI1 are Arg138, Glu142, Asp143, Asp177, 
Gly178, His179, Asp347 and Asp413, which correspond in HAB1 to 
Arg199, Glu203, Asp204, Asp243, Gly244, His245, Asp432 and Asp492, 
respectively. Both PP2Cs adopt a similar folding pattern as human PP2C, 
with two central five-stranded b-sheets sandwiched by two pairs of a-
helices. The catalytic site is located at the edge of the two central b-sheets 
and contains 3 atoms of either Mn
++
 or Mg
++
 ions. 
 The structural studies of different groups have made it possible to 
define the molecular mechanism of the ABA-dependent inhibition of PP2C 
activity through PYR/PYL ABA receptors. Although a clear picture 
emerges from these works (see below), important questions are still open, 
for instance, a clear discrepancy is observed with respect to the role of the 
dimeric PYR/PYL proteins in the mechanism of action. Indeed, both the 
work of Melcher et al., [15] and Miyazono et al., [16] (2009) omit any 
consideration on the dimeric nature of the ABA-receptor and the role, if 
any, of the dimer in the regulation of PYR/PYL function. Taking into 
account that experimental evidence indicates that both PYR1 and PYL2 are 
dimers in solution, the contribution of Yin et al., [19] is particularly 
relevant in this context. Thus, this group postulates that PYR/PYLs exist as 
inactive homodimers in cells, unable to bind or inhibit PP2Cs. However, 
yeast two hybrid and biochemical experiments indicate that different PYLs 
are able to interact with PP2Cs (in a non-inhibitory manner) in the absence 
of exogenous ABA [8,9,10]. On the other side, experimental evidence 
indicates that ABA-binding induces a conformational rearrangement of the 
receptor, which weakens the dimerization interface of the PYLs and, in 
turn, generates an interaction platform to contact the PP2C [19]  
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3.1. Mechanism of ABA-dependent inhibition of PP2Cs by 
PYR/PYL/RCAR receptors    
In the structure of PYL1-ABA-ABI1 and PYL2-ABA-HAB1, the ABA 
receptor (PYL1 or PYL2) contacts the PP2C using the gating loops that 
cover the ABA-binding pocket, i.e. the 3-4, 5-6 as well as the 7-5 
loop (Fig. 4C and 4D). On the other hand, the PP2C contacts the ABA 
receptor through its active site and a small protruding region, which has 
been called the flap sub-domain [26] and contains an important tryptophan 
residue (Fig. 6A). In the ternary complexes, access to the active-site cleft of 
the PP2C is blocked by the 3-4 loop of PYL proteins, where the Ser112 
of PYL1 or Ser89 of PYL2 establish hydrogen bonds with Gly180 of ABI1 
and Gly246 of HAB1 and the metal-stabilizing residue Glu142 of ABI1 
and Glu203 of HAB1, respectively (Fig. 6B) explaining the inhibitory 
action of receptor-hormone complexes on the activity of these 
phosphatases. Indeed, experiments by Melcher et al., [15] using a SnRK2.6 
peptide that acts as physiological substrate of HAB1 indicate a competitive 
inhibitor mechanism between ABA-bound PYL2 and HAB1 in  agreement 
with  the structural data. These results however, contrast with those 
reported by Ma et al., [9], which using a non-peptidic PP2C substrate 
(methyl-umbelliferyl-phosphate) concluded that the mode of inhibition of 
ABI2 by RCAR1/PYL9 occurs through non-competitive inactivation of the 
enzyme.   
In addition to the contact with the active-site cleft of the PP2C, 
amino acid residues Trp300 and Trp385 of ABI1 or HAB1, respectively, 
located at the flap sub-domain of the PP2C, are critical for the interaction 
with ABA-bound PYR/PYLs (Figure 6 A). This residue points into the 
ABA-binding pocket (through the loops that cover ABA) and establishes a 
water-mediated hydrogen-bond to the ketone group of ABA. This link has 
been interpreted for some authors as a direct proof that the PP2C serves as 
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a co-receptor of ABA [15,16]. An alternative point of view is that most of 
the ABA molecule is previously buried within the ABA-binding pocket of 
the ABA-receptor and only one water-mediated hydrogen bond is 
established between ABA and the PP2C upon interaction of the ABA-
bound PYL protein with the PP2C [19]. However, the work of Melcher et 
al., [15] shows that upon insertion of Trp385 of HAB1 into the PYL2 
ABA-binding pocket, the 3-4 (SGPLA residues) and 5-6 (HRL) loops 
undergo a conformational change, generating additional contacts with the 
ABA molecule. Therefore, Trp385 would act as a locking mechanism to 
keep the 3-4 and 5-6 loops in the closed conformation. Similar 
conclusions were reached by Miyazono et al., [16], which concluded that 
the docking of Trp300 of ABI1 into the PYL1 ABA-binding pocket is 
necessary for the 3-4 loop to be properly located into the active site of 
ABI1. Modeling of the Trp385A mutation in the PYL2-ABA-ΔNHAB1 
complex reveals the critical loss of the docking point provided by the 
interaction of the Trp residues with the ABA molecule (Fig. 6 D). Overall, 
these PP2C-induced conformational changes of PYR/PYL and ABA 
interaction would explain the higher ABA binding affinity measured for 
PYR/PYL in the presence of the catalytic core of the PP2Cs [9,10].  
 
3.2. abi1-1
G180D
, abi2-1
G168D
 and hab1
G246D
 hypermorphic enzymes 
The ternary complex PYL1-ABA-ABI1 [16,19] provides an explanation to 
the dominant gain-of-function phenotype of the abi1-1D mutation 
(equivalent to abi2-1D), which is a missense mutation that replaces Gly180 
by Asp (Gly168Asp in abi2-1). These mutations were isolated 25-years ago 
by genetic screenings in Arabidopsis, aimed to the identification of ABA-
insensitive mutants [27] and the cloning of the mutant loci provided 
pioneering insights into ABA signaling [28,29,30,31]. Both abi1-1D and 
abi2-1D are strong ABA-insensitive mutants that show diminished 
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response to ABA in seeds and vegetative tissues, however, analysis of loss-
of-function alleles indicates that ABI1 and ABI2 gene products, as well as 
other clade A PP2Cs, are negative regulators of ABA signaling 
[32,33,34,35]. Since the phenotype of the abi1-1D and abi2-1D dominant 
alleles is just the opposite of loss-of-function alleles, they can´t represent 
dominant negative alleles, as it was accurately noted by Robert et al., [36]. 
A molecular explanation is now provided by structural studies of the 
PYR/PYL/RCAR receptors in complex with ABA and the PP2Cs. For 
instance, Gly180 of ABI1 establishes a hydrogen bond with Ser112 of 
PYL1, which is a key residue for the blockage of the active-site cleft of the 
PP2C (see above). The replacement of the glycine residue by a bulkier 
aspartate will likely introduce steric hindrance for the interaction of the 3-
4 loop with the PP2C. Indeed, it has been demonstrated that abi1-1 
protein loses the interaction and is refractory to inhibition by PYR/PYL 
proteins [8,13], whereas this mutation does not block interaction with 
downstream targets of PP2Cs, such as SnRK2s [13,14,37].  
Similar considerations apply to the equivalent Gly246Asp mutation 
of HAB1 [14,36] and the ternary complex PYL2-ABA-HAB1 also 
provides a molecular explanation to the dominant nature of this mutation 
[15]. Thus, structural modeling of the mutated Asp246 residue in HAB1 
suggests that its larger side chain compared to Gly246 will collide with the 
3-4 loop of the ABA-bound PYR1/PYL2 [15] (Fig. 6C).  Moreover, 
biochemical studies performed with hab1
G246D
 reveal that this mutant 
PP2C, in contrast to HAB1 wt, escapes from ABA-dependent PYR1-
mediated inhibition, and it is able to dephosphorylate OST1 in the presence 
of ABA and PYR1 (Rodriguez P.L., unpublished results). Therefore, it 
qualifies as a hypermorphic mutation in the presence of ABA and a 
PYR/PYL receptor, although paradoxically, hab1
G246D
 as well as abi1
G180D
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and abi2
G168D
 proteins, have a lower specific activity as compared to wt in 
the absence of ABA.     
 
4. Mechanism of action of pyrabactin    
ABA-agonists harbour the potential to improve the yield of crop plants 
under drought stress or any other properties modulated by the ABA 
pathway in crop or ornamental plants. The identification of ABA 
antagonists would have also an important role in basic research, in order to 
manipulate ABA response in different tissues or developmental stages, 
which would represent a very useful tool to study ABA physiology. Recent 
studies with the first ABA agonist identified, pyrabactin, have provided a 
structural basis for understanding the selective activation of certain ABA 
receptors [20,21,22,38]. Additionally, these studies reveal that whereas 
pyrabactin is an ABA-agonist for some PYR/PYL/RCAR receptors, e.g. 
PYR1 and PYL1, it is an antagonist for other members of this family, e.g. 
PYL2. Comparison of the crystal structures of PYL1-pyrabactin-ABI1 and 
PYL1/PYL2-pyrabactin complexes has provided the mechanism to 
distinguish between productive and non-productive pyrabactin binding. In 
the case of PYR1 and PYL1, pyrabactin binds inside the receptor cavity 
and establishes interactions that stabilise the closed conformation of the 
gating loops, as ABA does. In the case of PYL2 however, pyrabactin also 
binds inside the receptor cavity but adopts a different conformation which 
does not promote closure of the gating loops. These findings also establish 
the concept of ABA receptor antagonism as well as a framework for 
modifying agonist selectivity.      
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Table 1. PDB codes of structural data on ABA-receptors of the 
PYR/PYL/RCAR family: 
Authors 
Apo-
structures 
ABA-PYR/PYL/RCAR 
bound structures 
ABA-PYR/PYL/RCAR-
PP2C complex structures 
Nature. 
Melcher et 
al.,2009 
apoPYL1 
3KAY 
apoPYL2 
3KAZ 
ABA-bound PYL2 
3KB0 
PYL2-ABA-HAB1 
3KB3 
Nature. 
Miyazono et 
al.,2009 
 
ABA-bound PYL1 
3JRS 
PYL1-ABA-ABI1 
3JRQ 
Nat. Struct. & 
Mol. Bio. 
Yin et al.,2009 
apoPYL2 
3KDH 
ABA-bound PYL2 
3KDI 
PYL1-ABA-ABI1 
3KDJ 
Science. 
Nishimura et 
al.,2009 
PYR1 
(subunit B) 
3K3K 
 
PYR1 (subunit A) 
3K3K 
 
 
Nature. 
Santiago et 
al.,2009 
PYR1 
(subunit B) 
3K90 
PYR1(subunit A) 
3K90 
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Fig. 1. Chemical structure of the phytohormone ABA and the seed ABA-
agonist pyrabactin. (A) 2D structure of the natural S(+) form of ABA. The 
red asterisk points out the C1’ asymmetric carbon of the molecule. (B). 3D 
structure of the two ABA enantiomers. The (-) enantiomer has been rotated 
to illustrate the structural difference of the ring methyl groups with respect 
to the (+) enantiomer. (C) 2D and 3D structures of pyrabactin.  
 
Fig. 2. Superposition of PYR1, PYL1 and PYL2 dimers. Figure generated 
with PyMOL (http://www.pymol.org) using the Protein Data Bank (PDB) 
codes 3KAZ (PYL2), 3KAY (PYL1) and 3K90 (PYR1).  
 
Fig. 3. ABA binding in the PYR1 cavity. (A) ABA (in light blue) buried in 
the PYR1 cavity. Lys59 (orange sticks), which is located at the bottom of 
the cavity, establishes a direct polar contact between its amine group and 
the carboxylate group of ABA. Interactions of Glu94, Glu141, Ser122 and 
Tyr120 (red sticks) with the carboxylate group are established through 
hydrogen bonds mediated by water molecules. (B) 2D map of interactions 
between ABA and PYR1[18]. Hemispheres represent hydrophobic 
interactions whereas polar interactions are represented by lines. HOH 
indicates water molecules. The yellow ribbon around the ABA molecule 
indicates low solvent accessibility.  
 
Fig. 4. Induction of conformational changes in the gating loops 
surrounding the PYR1 cavity upon ABA binding. Interaction of PYL2 and 
the catalytic core of HAB1. (A) Open conformation of the loops 3-4, 
S85GLPA89, and 5-6, H115RLT118, (in red), which maintains an open 
passage for ABA entry into the cavity. (B) ABA binding induces the closed 
conformation of the gating loops, which fold over the hormone and bury it 
into the cavity. In light blue, region comprising the loop between 7 and N-
 20 
terminal part of the α5 (M147PEGNSEDDTRM158), which is also involved 
in stabilizing ABA into the cavity. (C) Surface representation of the 
complex PYL2-ABA-ΔNHAB1. In red, the PYL2 surface generated by the 
closed conformation of the gating loops. In light blue, the region above 
indicated. (D) Detail of the loops and α-helix of PYL2 involved in the 
contact with the PP2C (purple).  
 
Fig. 5. Amino acid sequence and secondary structure alignment of plant 
PP2Cs with the catalytic core of human PP2C (residues 1-300). Figure 
generated with ESPript 2.2 [39]. Colour codes indicate the amino acid 
residues involved in the interaction with ABA receptors and contact points 
with phosphate, metal, ABA and hypermorphic mutations.  
 
Fig. 6. Structural details of the PYR/PYL/RCAR-ABA-PP2C complex. (A) 
Overview of contact points between PYL2 and the catalytic core of HAB1. 
The PP2C contacts the receptor through its active site and the flap region 
containing the Trp385 residue. Detail of the interactions involving this 
residue, the PYL2 gating loops, containing Pro92 and Arg120 residues, and 
the ketone group of ABA. The contacts are coordinated through a water 
molecule (in blue) located at the narrow channel between the loops. Mn
++
 
ions are marked as pink dots. (B) Detail of the interaction between the 
PYL2 loop containing the Ser89 residue and the phosphatase active site, 
emphasizing Gly246 and Glu203 residues. Hydrogen bonds are indicated 
by dotted lines. (C). Modeling of the Gly246Asp mutation in the HAB1 
active site. This amino acid substitution leads to disruption of the hydrogen 
bonds shown in B and steric hindrance for the interaction with the PYL2 
loop. (D) Modeling of a Trp385Ala mutation in HAB1. This mutation leads 
to loss of the docking point provided by the interaction of the Trp residue 
with the ABA molecule.  
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pyrabactin. (A) 2D structure of the natural S(+) form of ABA. The red asterisk
points out the C1’ asymmetric carbon of the molecule. (B). 3D structure of the
two ABA enantiomers. The (-) enantiomer has been rotated to illustrate the
structural difference of the ring methyl groups with respect to the (+) enantiomer.
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ABA binding. Interaction of PYL2 and the catalytic core of HAB1. (A) Open conformation of the
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ABA entry into the cavity. (B) ABA binding induces the closed conformation of the gating loops,
which fold over the hormone and bury it into the cavity. In light blue, region comprising the loop
between b7 and N-terminal part of the α5 (M147PEGNSEDDTRM158), which is also involved in
stabilizing ABA into the cavity. (C) Surface representation of the complex PYL2-ABA-ΔNHAB1. In
red, the PYL2 surface generated by the closed conformation of the gating loops. In light blue, the
region above indicated. (D) Detail of the loops and α-helix of PYL2 involved in the contact with the
PP2C (purple).
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(A) Overview of contact points between PYL2 and the catalytic core of
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